Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 USD | +11.78% | +16.67% | +55.56% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 33.33M | Capitalization | 69.48M |
---|---|---|---|---|---|
Net income 2024 * | -47M | Net income 2025 * | -33M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.08 x |
P/E ratio 2024 * |
-2.49
x | P/E ratio 2025 * |
-4.49
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.99% |
Latest transcript on Eledon Pharmaceuticals, Inc.
1 day | +11.78% | ||
1 week | +16.67% | ||
Current month | +17.15% | ||
1 month | +75.00% | ||
3 months | +53.01% | ||
6 months | +124.00% | ||
Current year | +55.56% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-04-30 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 21-03-14 |
Steven N. Perrin
PSD | President | 59 | 20-09-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 17-04-30 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 20-09-13 |
John S. McBride
BRD | Director/Board Member | 72 | 17-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 2.8 | +11.78% | 572,048 |
24-05-15 | 2.505 | +7.05% | 143,937 |
24-05-14 | 2.34 | +6.85% | 135,948 |
24-05-13 | 2.19 | -5.19% | 237,726 |
24-05-10 | 2.31 | -3.75% | 197,005 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.56% | 69.48M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- ELDN Stock